Epidemiology, Etiology, Diagnosis and Treatment of Prostate Cancer
Provides updated knowledge about epidemiology, etiology, diagnosis, and treatment of prostate cancer.
Prostate cancer is more common in men over the age of 65 years. There are 15% cases with positive familyhistory of prostate cancer Worldwide. Prostate cancer is the second leading cause of death among the U.S. men.Prostate cancer incidence is strongly related to age with the highest rates in older man. Globally millions ofpeople are suffering from this disease. This study aims to provide awareness about prostate cancer as well as anupdated knowledge about the epidemiology, etiology, diagnosis and treatment of prostate cancer.
Evidence level: Irányelv / elfogadott gyakorlat. Magas szintű klinikai elfogadottság.
Related signals
- Apalutamide Treatment and Metastasis‑free Survival in Prostate Cancer
- The prostate cancer conundrum revisited: Treatment changes and prostate cancer mortality declines
- The contemporary management of prostate cancer
- Extracellular TROP2 Fragment Identified as a Potential Biomarker and Metastasis Driver
- Overall survival of prostate cancer patients treated with Lu‑177 PSMA 617 (Pluvicto®) in a multidisciplinary setting— a single center experience